Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
CAH

CAH - Cardinal Health Inc Stock Price, Fair Value and News

110.17USD-0.44 (-0.40%)Market Closed

Market Summary

CAH
USD110.17-0.44
Market Closed
-0.40%

CAH Alerts

  • Big jump in Earnings (Y/Y)

CAH Stock Price

View Fullscreen

CAH RSI Chart

CAH Valuation

Market Cap

26.9B

Price/Earnings (Trailing)

42.1

Price/Sales (Trailing)

0.12

EV/EBITDA

13.66

Price/Free Cashflow

7.86

CAH Price/Sales (Trailing)

CAH Profitability

EBT Margin

0.52%

Return on Equity

23.42%

Return on Assets

1.37%

Free Cashflow Yield

12.72%

CAH Fundamentals

CAH Revenue

Revenue (TTM)

216.1B

Rev. Growth (Yr)

11.61%

Rev. Growth (Qtr)

4.9%

CAH Earnings

Earnings (TTM)

639.0M

Earnings Growth (Yr)

371.54%

Earnings Growth (Qtr)

7.0K%

Breaking Down CAH Revenue

52 Week Range

68.53111.29
(Low)(High)

Last 7 days

-0.5%

Last 30 days

-1.3%

Last 90 days

1.0%

Trailing 12 Months

30.8%

How does CAH drawdown profile look like?

CAH Financial Health

Current Ratio

0.98

Debt/Equity

1.3

Debt/Cashflow

1.12

CAH Investor Care

Dividend Yield

1.8%

Dividend/Share (TTM)

1.99

Buy Backs (1Y)

5.59%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023198.7B205.0B210.2B216.1B
2022176.8B181.4B187.0B193.0B
2021156.6B162.5B167.4B171.3B
2020153.6B152.9B154.6B156.5B
2019143.5B145.5B147.7B149.7B
2018134.4B136.8B139.4B141.9B
2017128.4B130.0B130.6B132.6B
2016117.7B121.5B125.5B127.2B
201597.9B102.5B106.5B112.4B
201493.6B91.1B90.6B93.9B
2013102.4B101.1B99.7B96.7B
2012107.6B107.6B106.6B104.8B
2011100.3B102.6B105.0B106.7B
201098.4B98.5B98.2B98.6B
200993.8B96.0B97.3B98.1B
2008087.4B89.6B91.7B

Tracking the Latest Insider Buys and Sells of Cardinal Health Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Feb 15, 2024
alt aaron e
sold (taxes)
-198,712
103
-1,919
chief financial officer
Feb 15, 2024
greene michelle d.
sold (taxes)
-68,757
103
-664
chief information officer
Dec 01, 2023
weitzman deborah
sold (taxes)
-68,317
107
-638
ceo, pharmaceutical segment
Dec 01, 2023
snow ola m
sold (taxes)
-40,904
107
-382
chief human resources officer
Dec 01, 2023
scherer mary c.
sold (taxes)
-23,236
107
-217
chief accounting officer
Nov 27, 2023
weitzman deborah
acquired
2,048,360
74.103
27,642
ceo, pharmaceutical segment
Nov 27, 2023
weitzman deborah
sold
-3,895,410
106
-36,642
ceo, pharmaceutical segment
Nov 15, 2023
hall patricia hemingway
acquired
-
-
1,965
-
Nov 15, 2023
brennan michelle
acquired
-
-
1,965
-
Nov 15, 2023
mundkur christine
acquired
-
-
1,965
-

1–10 of 50

Which funds bought or sold CAH recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Mar 11, 2024
VANGUARD GROUP INC
reduced
-2.57
365,403,000
3,151,620,000
0.07%
Mar 11, 2024
Wahed Invest LLC
added
5.36
79,393
424,066
0.12%
Mar 08, 2024
TRUST CO OF VERMONT
reduced
-8.72
56,176
996,610
0.07%
Mar 05, 2024
Fisher Asset Management, LLC
added
39.3
161,459
422,791
-%
Mar 04, 2024
TUCKER ASSET MANAGEMENT LLC
reduced
-10.71
20,634
582,967
0.15%
Mar 01, 2024
ROYAL LONDON ASSET MANAGEMENT LTD
added
1.93
1,559,350
10,070,800
0.03%
Mar 01, 2024
GOLDMAN SACHS GROUP INC
added
107
150,735,000
257,408,000
0.02%
Mar 01, 2024
Pineridge Advisors LLC
new
-
3,856
3,856
-%
Feb 29, 2024
Tortoise Investment Management, LLC
unchanged
-
1,461
10,189
-%
Feb 29, 2024
Quintet Private Bank (Europe) S.A.
sold off
-100
-150,372
-
-%

1–10 of 48

Are Funds Buying or Selling CAH?

Are funds buying CAH calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CAH
No. of Funds

Unveiling Cardinal Health Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
12.69%
31,266,013
SC 13G/A
Jan 30, 2024
state street corp
5.90%
14,540,655
SC 13G/A
Jan 24, 2024
blackrock inc.
10.6%
26,152,886
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
1.9%
4,994,087
SC 13G/A
Feb 09, 2023
vanguard group inc
11.95%
31,320,204
SC 13G/A
Feb 06, 2023
state street corp
6.70%
17,568,683
SC 13G/A
Jan 26, 2023
blackrock inc.
11.3%
29,572,939
SC 13G/A
Jan 20, 2023
blackrock inc.
11.3%
29,572,939
SC 13G/A
Sep 08, 2022
blackrock inc.
10.6%
28,946,151
SC 13G
Feb 14, 2022
price t rowe associates inc /md/
5.3%
15,028,767
SC 13G

Recent SEC filings of Cardinal Health Inc

View All Filings
Date Filed Form Type Document
Mar 01, 2024
3
Insider Trading
Feb 28, 2024
8-K
Current Report
Feb 20, 2024
8-K
Current Report
Feb 16, 2024
424B5
Prospectus Filed
Feb 16, 2024
4
Insider Trading
Feb 16, 2024
4
Insider Trading
Feb 14, 2024
FWP
Prospectus Filed
Feb 14, 2024
424B5
Prospectus Filed
Feb 13, 2024
SC 13G/A
Major Ownership Report
Feb 01, 2024
8-K
Current Report

What is the Fair Value of CAH?

Loading...
Disclaimer: Conduct thorough research and seek guidance from a certified financial advisor prior to finalizing any investment choices.

Peers (Alternatives to Cardinal Health Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
200.4B
40.1B
0.08% 5.41%
35.02
5
-8.12% -17.45%
68.4B
19.5B
1.90% -2.48%
54.45
3.51
4.02% -22.04%
23.6B
3.9B
13.67% -2.23%
53.05
6.11
3.42% 23.09%
21.1B
14.9B
3.05% 1.38%
7.96
1.43
2.12% 209.17%
MID-CAP
9.7B
2.7B
6.89% -27.73%
-15.29
3.65
-4.68% 82.43%
9.6B
12.3B
2.56% -12.12%
23.04
0.78
-2.44% -22.68%
9.3B
3.5B
8.76% 25.90%
32.72
2.67
4.97% 18.89%
6.8B
4.0B
-8.15% -6.44%
-50.63
1.72
1.10% 85.84%
3.5B
366.4M
-1.40% 20.18%
-568.09
9.44
33.86% 89.80%
2.4B
6.6B
-4.32% -4.67%
12.6
0.37
2.78% -0.87%
SMALL-CAP
1.4B
3.2B
8.08% -63.68%
-2.02
0.43
7.73% -1066.14%
377.8M
166.7M
8.18% -20.52%
-4.57
2.27
6.67% -456.34%
214.0M
329.5M
3.17% -52.24%
-15.16
0.65
0.49% 64.22%
62.0M
50.3M
4.50% -30.54%
-4.09
1.23
3.23% 20.81%
4.5M
3.7M
-15.66% 215.09%
-0.37
1.21
5.77% 8.23%

Cardinal Health Inc News

Latest updates
Yahoo Finance • 8 hours ago
MarketWatch • 15 Mar 2024 • 10:05 pm
MarketWatch • 11 Mar 2024 • 10:03 pm
Yahoo Finance • 07 Mar 2024 • 02:40 pm

Cardinal Health Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue4.9%57,44554,76353,45350,48751,46949,60347,10344,83645,45743,96842,58639,27541,54139,06536,68939,15739,73537,34137,35335,22837,740
Gross Profit4.4%1,8461,7681,8271,7851,6631,6141,6051,6821,6161,6421,4751,8121,7761,7151,5901,8851,7141,6791,6741,7641,730
  S&GA Expenses7.2%1,2831,1971,2671,1791,1911,1971,1551,1371,1511,1141,1291,1201,1471,1371,1371,1651,1631,1071,1681,0971,064
EBITDA Margin44.1%0.01*0.01*0.01*0.01*0.00*0.00*0.00*0.00*0.00*0.01*0.01*0.01*---------
Interest Expenses-42.9%8.0014.0015.0028.0025.0025.0034.0038.0037.0040.0044.0045.0046.0045.0049.0060.0063.0066.0067.0075.0076.00
Income Taxes525.0%136-32.00187197-7.00-1.00-1651,253-1,02297.004.00320-203-410107-127-59.00-42344.0074.00126
Earnings Before Taxes1984.6%490-26.00121544-137110-28.00-137-973369119440427-663815478279-5,344239370407
EBT Margin118.6%0.01*0.00*0.00*0.00*0.00*-0.01*0.00*0.00*0.00*0.01*0.00*0.01*---------
Net Income6960.0%3535.00-64.00345-130110138-1,39149.00271116119629-253656350220-4,922194296280
Net Income Margin298.4%0.00*0.00*0.00*0.00*-0.01*-0.01*-0.01*-0.01*0.00*0.01*0.00*0.01*---------
Free Cashflow137.3%1,0754536411,252512-47.002,828-5011,121-713539177---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets6.5%46,57343,71043,41743,37744,48243,38743,87842,11143,68042,99344,45343,87444,71941,72740,76641,14841,04239,17940,96340,80940,462
  Current Assets8.6%37,65834,68833,83333,49734,59632,69632,93530,88431,84729,73131,04830,36230,11327,03025,94025,84825,73623,71525,74725,58225,091
    Cash Equivalents19.1%4,5913,8544,0433,9903,6543,4924,7172,3563,1612,4633,4073,4993,7372,7462,7712,3291,6591,2122,5313,4382,182
  Inventory8.6%18,45116,98715,94016,62017,26315,89115,63615,49314,94114,72014,59414,32914,44313,43913,19812,80813,79912,45812,82212,62213,037
  Net PPE0.2%2,4462,4412,4622,3622,3412,3392,3612,2982,3212,3362,3602,3152,3862,3692,3662,2992,3012,3242,3562,3222,376
  Current Liabilities9.2%38,28635,06533,70632,50333,21231,55930,55028,71527,72926,49927,62425,32325,75024,01623,61524,67124,89022,54924,10923,91923,824
  Long Term Debt-9.1%3,5353,8903,9094,7084,6854,6894,7354,7515,3425,3535,3656,7156,7206,7286,7656,7546,7427,3607,5797,6297,599
Shareholder's Equity---------1,0021,3961,7941,7941,9751,4251,7921,2061,0029036,3306,2326,043
  Retained Earnings35.0%-425-654-534-342-560-301-280-2811,2451,3351,2051,2331,2557711,1706564493715,4345,3865,233
Shares Outstanding-0.8%247249261263261271279281279287292293---------
Minority Interest100.0%2.001.001.002.001.001.003.004.004.003.003.004.004.003.003.003.003.003.002.002.00-
Float-----19,775---14,224---15,694---14,729---13,268
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations118.2%1,1895458581,36159723.002,992-4191,195-6466652771,2172702401,676697-6535061,480371
  Share Based Compensation-3.4%28.0029.0027.0021.0025.0023.0016.0023.0018.0024.005.0033.0023.0028.0022.0027.0021.0020.0018.0023.0022.00
Cashflow From Investing-66.7%-105-63.00-206-91.00-87.00-70.00-204-44.00-47.00862-88.00-99.00-97.00-94.00742-98.00-78.00-73.00-173-84.00-84.00
Cashflow From Financing47.0%-353-666-592-934-362-1,163-415-340-444-1,264-649-324-146-198-528-912-175-585-1,243-142-144
  Dividend Payments-5.3%124131126128129142134136140149141143143146141141141146142142143
  Buy Backs-80.0%10050065050.001501,00022020.0040.00500-200----35.0070.00350---

CAH Income Statement

2023-12-31
Condensed Consolidated Statements of Earnings - USD ($)
shares in Millions, $ in Millions
3 Months Ended6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Revenue$ 57,445$ 51,469$ 112,208$ 101,072
Cost of products sold55,59949,806108,59497,795
Gross margin1,8461,6633,6143,277
Operating expenses:    
Distribution, selling, general and administrative expenses1,2831,1912,4802,388
Restructuring and employee severance28175346
Amortization and other acquisition-related costs6371127142
Impairments and (gain)/loss on disposal of assets, net1710538863
Litigation (recoveries)/charges, net(11)(207)(52)(180)
Operating earnings/(loss)482(119)46818
Other (income)/expense, net(16)(7)(18)(5)
Interest expense, net8252250
Earnings/(loss) before income taxes490(137)464(27)
Provision for/(benefit from) income taxes136(7)104(8)
Net earnings/(loss)354(130)360(19)
Less: Net earnings attributable to noncontrolling interests(1)0(2)(1)
Net earnings/(loss) attributable to Cardinal Health, Inc.$ 353$ (130)$ 358$ (20)
Earnings/(Loss) per common share attributable to Cardinal Health, Inc.:    
Basic (in shares)$ 1.44$ (0.50)$ 1.45$ (0.08)
Diluted (in shares)$ 1.43$ (0.50)$ 1.44$ (0.08)
Weighted-average number of common shares outstanding:    
Basic (in shares)245261247266
Diluted (in shares)246261248266
Cash dividends declared per common share$ 0.5006$ 0.4957$ 1.0012$ 0.9914

CAH Balance Sheet

2023-12-31
Condensed Consolidated Balance Sheets - USD ($)
shares in Thousands, $ in Millions
Dec. 31, 2023
Jun. 30, 2023
Current assets:  
Cash and equivalents$ 4,591$ 4,043
Trade receivables, net11,78811,344
Inventories, net18,45115,940
Prepaid expenses and other2,8162,362
Assets held for sale12144
Total current assets37,65833,833
Property and equipment, net2,4462,462
Goodwill and other intangibles, net5,3716,081
Other assets1,0981,041
Total assets46,57343,417
Current liabilities:  
Accounts payable34,25929,813
Current portion of long-term obligations and other short-term borrowings1,188792
Other accrued liabilities2,8393,059
Liabilities related to assets held for sale042
Total current liabilities38,28633,706
Long-term obligations, less current portion3,5353,909
Deferred income taxes and other liabilities8,1998,653
Preferred shares, without par value:  
Authorized—500 thousand shares, Issued—none$ 0$ 0
Preferred shares, authorized500500
Preferred shares, issued00
Common shares, without par value:  
Authorized—755 million shares, Issued—327 million shares at December 31, 2023 and June 30, 2023$ 2,855$ 2,747
Common shares, authorized755,000755,000
Common shares, issued327,000327,000
Accumulated deficit$ (425)$ (534)
Common shares in treasury, at cost: 83 million shares and 76 million shares at December 31, 2023 and June 30, 2023, respectively$ (5,724)$ (4,914)
Common shares in treasury83,00076,000
Accumulated other comprehensive loss$ (155)$ (151)
Total Cardinal Health, Inc. shareholders' deficit(3,449)(2,852)
Noncontrolling interests21
Total shareholders’ deficit(3,447)(2,851)
Total liabilities and shareholders’ deficit$ 46,573$ 43,417
CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
 CEO
 WEBSITEwww.cardinalhealth.com
 EMPLOYEES47040

Cardinal Health Inc Frequently Asked Questions


What is the ticker symbol for Cardinal Health Inc? What does CAH stand for in stocks?

CAH is the stock ticker symbol of Cardinal Health Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Cardinal Health Inc (CAH)?

As of Fri Mar 15 2024, market cap of Cardinal Health Inc is 26.9 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CAH stock?

You can check CAH's fair value in chart for subscribers.

What is the fair value of CAH stock?

You can check CAH's fair value in chart for subscribers. The fair value of Cardinal Health Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Cardinal Health Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CAH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Cardinal Health Inc a good stock to buy?

The fair value guage provides a quick view whether CAH is over valued or under valued. Whether Cardinal Health Inc is cheap or expensive depends on the assumptions which impact Cardinal Health Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CAH.

What is Cardinal Health Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Mar 15 2024, CAH's PE ratio (Price to Earnings) is 42.1 and Price to Sales (PS) ratio is 0.12. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CAH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Cardinal Health Inc's stock?

In the past 10 years, Cardinal Health Inc has provided 0.068 (multiply by 100 for percentage) rate of return.